Tetradecylacetate

Tetradecylacetate

SCHEMBL537712

CCCCCCCCCCCCCCOC(C)=O.CCOCC

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.68
TSHR P16473 4/20 0.59
NAAA Q02083 1/20 0.55
CES2 O00748 1/20 0.53
EPHX1 P07099 1/20 0.52
HCAR2 Q8TDS4 1/20 0.47
RAD52 P43351 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
LMNA P02545 2/20 0.46
HSD17B10 Q99714 1/20 0.46
FAAH O00519 2/20 0.46
ACHE P22303 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Octyl Acetate SCHEMBL4930248 1.00 ALDH1A1 (0.68) ALDH1A1TSHRNAAACES2EPHX1
Acetic Acid Hexadecyl Ester SCHEMBL2863328 1.00 ALDH1A1 (0.68) ALDH1A1TSHRNAAACES2EPHX1
Decylacetate SCHEMBL3426391 1.00 ALDH1A1 (0.68) ALDH1A1TSHRNAAACES2EPHX1
Hexyl Acetate SCHEMBL7690856 1.00 ALDH1A1 (0.68) ALDH1A1TSHRNAAACES2EPHX1
Tridecylacetate SCHEMBL2400935 1.00 ALDH1A1 (0.68) ALDH1A1TSHRNAAACES2EPHX1
Ether SCHEMBL4931894 1.00 ALDH1A1 (0.68) ALDH1A1TSHRNAAACES2EPHX1
Dodecylacetate SCHEMBL353028 1.00 ALDH1A1 (0.68) ALDH1A1TSHRNAAACES2EPHX1
Octyl Acetate SCHEMBL9751176 0.98 ALDH1A1 (0.65) ALDH1A1TSHRNAAACES2EPHX1
Decylacetate SCHEMBL22091864 0.98 ALDH1A1 (0.65) ALDH1A1TSHRNAAACES2EPHX1
Dodecylacetate SCHEMBL515330 0.98 ALDH1A1 (0.65) ALDH1A1TSHRNAAACES2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11207263-B2 Cosmetic compositions DOW SILICONES CORPORATION (US) 2021-12-28 US claimed
US-20200237639-A1 COSMETIC COMPOSITIONS DOW SILICONES CORP (US) 2020-07-30 US claimed
US-20200222302-A1 FILM FORMING COMPOSITIONS HAVING A TACK-FREE SURFACE DOW SILICONES CORPORATION 2020-07-16 US claimed
WO-2019045830-A1 COSMETIC COMPOSITIONS DOW SILICONES CORPORATION (US) 2019-03-07 WO claimed
WO-2019045831-A1 FILM FORMING COMPOSITIONS HAVING A TACK-FREE SURFACE DOW SILICONES CORPORATION (US) 2019-03-07 WO claimed
CN-101835457-B Two-part hair dye 花王株式会社 2016-10-12 CN claimed
CN-103079532-B Two-part foam hair dye KAO CORP 2015-03-25 CN claimed
CN-103079532-A Two-part foam hair dye KAO CORP 2013-05-01 CN claimed
US-5008100-A Stable sunscreens ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) 1991-04-16 US claimed
CN-115516086-A Compositions and methods for reducing allogeneic cell host rejection in apes ICP47 and variants 南京传奇生物科技有限公司 2022-12-23 CN disclosed
CN-111978250-B Fluorescent probe and application thereof in detecting hypochlorite 中国科学院大连化学物理研究所 2022-12-13 CN disclosed
US-11207263-B2 Cosmetic compositions DOW SILICONES CORPORATION (US) 2021-12-28 US disclosed
EP-3771336-A1 REPELLENT COMPOSITION Athenion AG (CH) 2021-02-03 EP disclosed
EP-3771335-A1 REPELLENT COMPOSITION Athenion AG (CH) 2021-02-03 EP disclosed
WO-1998013427-A1 TITANIUM-TIN-OXIDE NANOPARTICLES, COMPOSITIONS UTILIZING THE SAME, AND METHOD OF FORMING THE SAME SOUTHWEST RESEARCH INSTITUTE (US) 1998-04-02 WO disclosed
WO-1998013299-A1 Ti-Sn-O NANOCLUSTERS, METHOD FOR THEIR PRODUCTION AND THEIR USE COTY B.V. (NL) 1998-04-02 WO disclosed
US-5720805-A COMPLEX WITH SALT OF ALPHA-HYDROXY ACID; CHARGE TRANSFER COMPOUNDS SOUTHWEST RESEARCH INSTITUTE (US) 1998-02-24 US disclosed
EP-0342056-B1 Cosmetic composition UNILEVER PLC (GB) 1994-08-17 EP disclosed
US-4919846-A Conditioning low skin sensitivity SHISEIDO COMPANY LTD. (JP) 1990-04-24 US disclosed
EP-0342056-A2 Cosmetic composition UNILEVER PLC (GB) 1989-11-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200222302-A1 FILM FORMING COMPOSITIONS HAVING A TACK-FREE SURFACE C9, SCO2, H1-3 ALDH1A1 4351/4885TSHR 637/4885NAAA 4640/4885
US-20200237639-A1 COSMETIC COMPOSITIONS H1-0, H1-3, HRH3 ALDH1A1 3529/4885TSHR 625/4885NAAA 4304/4885
US-11207263-B2 Cosmetic compositions H1-0, H1-3, HRH3 ALDH1A1 3447/4885TSHR 492/4885NAAA 4220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.